341 related articles for article (PubMed ID: 22010344)
21. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
[TBL] [Abstract][Full Text] [Related]
22. [Application of reference extracts in quality control of traditional Chinese medicines].
Lu TL; Zhai WM; Cai BC; Zhou Y; Mao CQ; Li L
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(3):462-5. PubMed ID: 23668030
[TBL] [Abstract][Full Text] [Related]
23. Application of mid-infrared spectroscopy in the quality control of traditional Chinese medicines.
Sun S; Chen J; Zhou Q; Lu G; Chan K
Planta Med; 2010 Dec; 76(17):1987-96. PubMed ID: 21049394
[TBL] [Abstract][Full Text] [Related]
24. [Study on reference extracts for quality assessment on traditional Chinese medicines based on akebiae saponin].
Yuan X; Gao H; Wang Z; Zhang Q
Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2413-6. PubMed ID: 23234140
[TBL] [Abstract][Full Text] [Related]
25. [Comparative study on the original plant differences of Chinese traditional medicines and Japanese Kampo medicines].
Chen HB; Cai SQ; Mikage M; Naoko K
Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):715-8, 822. PubMed ID: 15506274
[TBL] [Abstract][Full Text] [Related]
26. [Application of new technologies and methods in morphological and microscopic identification of Chinese materia medica].
Long F; Li H; Li P
Zhongguo Zhong Yao Za Zhi; 2012 Apr; 37(8):1076-80. PubMed ID: 22779353
[TBL] [Abstract][Full Text] [Related]
27. [Status of content analysis of pyrrolizidine alkaloids in food and herbs].
Yan Z; Si-Qi MA; Fei-Fei Y; Jian-Yong SI; Qing WU; Yong-Hong L
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5421-5428. PubMed ID: 33350201
[TBL] [Abstract][Full Text] [Related]
28. Determination of Toxic Pyrrolizidine Alkaloids in Traditional Chinese Herbal Medicines by UPLC-MS/MS and Accompanying Risk Assessment for Human Health.
Wang J; Zhang M; Chen L; Qiao Y; Ma S; Sun D; Si J; Liao Y
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809536
[TBL] [Abstract][Full Text] [Related]
29. Analysis of potential risks of clinical application of Yi Dian Hong and its proprietary Chinese medicines: A review.
Chen G; Mao L; Xia H; Zhu L; Huang J; Lu Y; Liu X; Tang T
Medicine (Baltimore); 2024 Jan; 103(4):e36860. PubMed ID: 38277559
[TBL] [Abstract][Full Text] [Related]
30. Pro-toxic dehydropyrrolizidine alkaloids in the traditional Andean herbal medicine "asmachilca".
Colegate SM; Boppré M; Monzón J; Betz JM
J Ethnopharmacol; 2015 Aug; 172():179-94. PubMed ID: 26087231
[TBL] [Abstract][Full Text] [Related]
31. Quality and safety of Chinese herbal medicines guided by a systems biology perspective.
Wang J; van der Heijden R; Spruit S; Hankermeier T; Chan K; van der Greef J; Xu G; Wang M
J Ethnopharmacol; 2009 Oct; 126(1):31-41. PubMed ID: 19683045
[TBL] [Abstract][Full Text] [Related]
32. Risk assessment on the use of herbal medicinal products containing pyrrolizidine alkaloids.
Allgaier C; Franz S
Regul Toxicol Pharmacol; 2015 Nov; 73(2):494-500. PubMed ID: 26399164
[TBL] [Abstract][Full Text] [Related]
33. Identification of five hepatotoxic pyrrolizidine alkaloids in a commonly used traditional Chinese medicinal herb, Herba Senecionis scandentis (Qianliguang).
Li SL; Lin G; Fu PP; Chan CL; Li M; Jiang ZH; Zhao ZZ
Rapid Commun Mass Spectrom; 2008; 22(4):591-602. PubMed ID: 18220326
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary study on general regulations for processing of different processing procedures of prepared slices of Chinese crude drugs in China].
Huang QW; Li H; Huang XJ; Yu JY
Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):153-6. PubMed ID: 24754186
[TBL] [Abstract][Full Text] [Related]
35. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.
Chan K; Shaw D; Simmonds MS; Leon CJ; Xu Q; Lu A; Sutherland I; Ignatova S; Zhu YP; Verpoorte R; Williamson EM; Duez P
J Ethnopharmacol; 2012 Apr; 140(3):469-75. PubMed ID: 22330011
[TBL] [Abstract][Full Text] [Related]
36. Chromatography of medicinal plants and Chinese traditional medicines.
Li F; Sun S; Wang J; Wang D
Biomed Chromatogr; 1998; 12(2):78-85. PubMed ID: 9568275
[TBL] [Abstract][Full Text] [Related]
37. Separation and determination of toxic pyrrolizidine alkaloids in traditional Chinese herbal medicines by micellar electrokinetic chromatography with organic modifier.
Yu L; Xu Y; Feng H; Li SF
Electrophoresis; 2005 Sep; 26(17):3397-404. PubMed ID: 16080213
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous characterization of pyrrolizidine alkaloids and N-oxides in Gynura segetum by liquid chromatography/ion trap mass spectrometry.
Qi X; Wu B; Cheng Y; Qu H
Rapid Commun Mass Spectrom; 2009 Jan; 23(2):291-302. PubMed ID: 19072862
[TBL] [Abstract][Full Text] [Related]
39. Qualitative and quantitative analysis of pyrrolizidine alkaloids for the entire process quality control from Senecio scandens to Senecio scandens-containing preparations by high performance liquid chromatography-tandem mass spectrometry.
Wang Y; Li Y; Cang S; Cai Q; Xu H; Wang Y; Liu R; Xu H; Li Q
J Mass Spectrom; 2020 Oct; 55(10):e4532. PubMed ID: 32662582
[TBL] [Abstract][Full Text] [Related]
40. [Discussion and analysis on determination term of medicinal materials and decotion pieces in Chinese pharmacopoeia (2010 edition, volume I )].
Liu D
Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(16):2116-8. PubMed ID: 21046743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
